<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:x="urn:schemas-microsoft-com:office:excel" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 12 (filtered medium)">
<title>Untitled 1</title>
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:10.0pt;
font-family:"Arial","sans-serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:"Arial","sans-serif";}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
p.auto-style1, li.auto-style1, div.auto-style1
{mso-style-name:auto-style1;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:7.5pt;
font-family:"Arial","sans-serif";}
p.auto-style2, li.auto-style2, div.auto-style2
{mso-style-name:auto-style2;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";
color:white;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Arial","sans-serif";
color:windowtext;
font-weight:normal;
font-style:normal;
text-decoration:none none;}
span.EmailStyle24
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle25
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.auto-style21
{mso-style-name:auto-style21;
color:white;}
span.auto-style11
{mso-style-name:auto-style11;
font-family:"Arial","sans-serif";}
span.EmailStyle28
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.apple-converted-space
{mso-style-name:apple-converted-space;}
span.xn-org
{mso-style-name:xn-org;}
span.EmailStyle31
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle32
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1461150745;
mso-list-type:hybrid;
mso-list-template-ids:-895033936 67698689 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;
font-family:Symbol;}
@list l0:level2
{mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level3
{mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level4
{mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level5
{mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level6
{mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level7
{mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level8
{mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level9
{mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="color:#1F497D">Hi All,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">As a follow up to Scott’s email below, here is some additional information that might serve this discussion:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo1"><![if !supportLists]><span style="font-family:Symbol;color:#1F497D"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="color:#1F497D">The pouch that Mallinckrodt donated is called
<a href="http://deterrasystem.com/">Deterra</a>, which is a rebranding of <a href="http://deterrasystem.com/2015/02/verde-technologies-introduces-deterra-drug-deactivation-system/">
Verde technologies</a>’ Medsaway technology. <o:p></o:p></span></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo1"><![if !supportLists]><span style="font-family:Symbol;color:#1F497D"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="color:#1F497D">If you follow the claims on the Deterra website about their “scientific research,” it takes you to several studies by their in-house scientist
<a href="http://deterrasystem.com/research/">that are <b>not</b> <b>peer reviewed</b></a>.
<o:p></o:p></span></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo1"><![if !supportLists]><span style="font-family:Symbol;color:#1F497D"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="color:#1F497D">On Deterra’s <a href="http://deterrasystem.com/faq/">
FAQ page</a>, it mentions that the ONDCP supports this kind of technology, a half-truth based on relatively vague statements in ONDCP’s
<a href="https://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/2015_national_drug_control_strategy.pdf">
2015 drug control strategy</a>). <o:p></o:p></span></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo1"><![if !supportLists]><span style="font-family:Symbol;color:#1F497D"><span style="mso-list:Ignore">·<span style="font:7.0pt "Times New Roman"">
</span></span></span><![endif]><span style="color:#1F497D">The FAQ page also states that “<b>Verde has been awarded a contract from the National Institute of Drug Abuse (NIDA), a part of the U.S. National Institute of Health (NIH), for the development of at-home
drug deactivation products</b>.”<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">So it appears there may finally be one government agency taking the lead on evaluating these pouches and other black-box deactivation technologies: NIH’s
</span><span style="color:#1F497D">National Institute on Drug Abuse</span><span style="color:#1F497D"> (NIDA). The following can be found on page 94 of this
<a href="file:///\\psiserver\Public%20Folder\Pharmaceuticals\7%20Resources\Destruction%20technology%20info\2013_US%20DHHS_Solicitation%20of%20NIH%20and%20CDC%20for%20Small%20Business%20Innovation%20Research%20Contract%20Proposals=%20DEACTIVATION%20TECHNOLOGIES.pdf">
NIH RFP for small businesses</a>:<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in">148 <b>Products for at-home Deactivation of Psychoactive Prescription Medicines</b>
<o:p></o:p></p>
<p class="MsoNormal" style="margin-left:1.0in"><span style="font-size:10.0pt">(Fast-Track proposals will be accepted.)
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:1.0in"><span style="font-size:10.0pt">Number of Anticipated Awards: 2-3
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:1.0in"><span style="font-size:10.0pt">Budget (total costs): Phase I: $150,000 for 6 months; Phase II: $1,000,000 for 2 years
<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><u>Objective</u>: This topic addresses the need to fund research and development activities to promote the commercial development and testing of an inexpensive prescription medicine disposal system that would provide
<b>a simple means for patients</b> (prescription drug “end-users” defined by the Drug Enforcement Administration) or members of their household
<b>to safely render prescription drugs unusable and effectively contained</b> <b>
in order to minimize the potential for diversion or accidental exposure to children or pets</b>. Methods proposed may include approaches or agents that mechanically destroy or chemically neutralize prescription drugs for either safe home disposal or safe transit
for disposal by another facility. For example, such a product or agent could be distributed by practitioners and pharmacies along with scheduled medications. As an ancillary benefit,
<b>such a product holds the potential to minimize drugs entering the watershed and other adverse environmental effects.</b><span style="color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="color:red">Perhaps NIDA will ultimately be in charge of vetting in-home deactivation technology for residential pharmaceutical waste</span></b><span style="color:#1F497D">. Something to keep an eye on.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Best,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Vivian<o:p></o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;color:#333333">______________________________<br>
Vivian Fuhrman<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:10.0pt;color:#404040">Associate for Policy and Programs</span><span style="color:#404040"><o:p></o:p></span></p>
<p class="MsoNormal"><i><span style="font-size:10.0pt;color:#333333">Product Stewardship Institute, Inc.<br>
</span></i><span style="font-size:10.0pt;color:#333333">29 Stanhope St., 3rd Floor, Boston, MA 02116<br>
P: (617) 236-4771 F: (617) 236-4766<br>
</span><span style="font-size:10.0pt;color:#1F497D"><a href="http://www.productstewardship.us/" target="_blank"><span style="color:#333333">www.productstewardship.us</span></a><br>
<a href="mailto:vivian@productstewardship.us" target="_blank"><span style="color:#333333">vivian@productstewardship.us</span></a></span><span style="color:#1F497D"><o:p></o:p></span></p>
<p class="MsoNormal"><i><span style="font-size:10.0pt;color:#333333">The Product Stewardship Institute, Inc. is an equal opportunity provider and employer.<o:p></o:p></span></i></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
</div>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> Pharmwaste [mailto:pharmwaste-bounces@lists.dep.state.fl.us]
<b>On Behalf Of </b>Scott Cassel<br>
<b>Sent:</b> Wednesday, June 29, 2016 8:12 PM<br>
<b>To:</b> pharmwaste@lists.dep.state.fl.us<br>
<b>Subject:</b> [Pharmwaste] Mallinckrodt Pharmaceuticals donating one million drug deactivation pouches to support the fight against prescription drug abuse<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="color:#1F497D"><a href="http://www.prnewswire.com/news-releases/mallinckrodt-donates-one-million-drug-deactivation-pouches-to-support-us-fight-against-prescription-drug-abuse-300286092.html">http://www.prnewswire.com/news-releases/mallinckrodt-donates-one-million-drug-deactivation-pouches-to-support-us-fight-against-prescription-drug-abuse-300286092.html</a><o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Thanks to Anne LeMere of Unity Hospice for sharing Mallinckrodt’s press release, which states that: “</span>The pouch-based systems that Mallinckrodt is donating deactivate prescription drugs and render chemical
compounds safe for landfills. The pouches are also biodegradable, providing an environmentally responsible way to deactivate and dispose of drugs.”<span style="color:#1F497D"> <o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Can any government officials on this list verify that their agencies approve of these pouches being landfilled?
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Before millions of these pouches end up in landfills, I would like to know whether government officials WANT them in their landfills and consider this a safe disposal method. Has anyone seen the company’s data
showing the criteria they use for landfill safety and biodegradability?<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Thanks, <br>
Scott<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<div>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Arial","sans-serif";color:black">________________________________<o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Arial","sans-serif";color:black">Scott Cassel<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial","sans-serif";color:black">Chief<b>
</b>Executive Officer/Founder<br>
<i>Product Stewardship Institute, Inc.</i><br>
29 Stanhope Street, Boston, MA 02116<br>
617-236-4822 (ph); 617-236-4766 (fax) <br>
</span><span style="color:black"><a href="mailto:scott@productstewardship.us"><span style="font-size:10.0pt;font-family:"Arial","sans-serif"">scott@productstewardship.us</span></a><br>
<a href="http://www.productstewardship.us/"><span style="font-size:10.0pt;font-family:"Arial","sans-serif"">www.productstewardship.us</span></a></span><b><span style="font-size:10.0pt;font-family:"Arial","sans-serif";color:black"><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="color:gray">Click to follow us on </span></b><span style="color:#1F497D"><a href="http://www.facebook.com/pages/Product-Stewardship-Institute/224328115936?ref=ts"><b><span style="color:#4F81BD">Facebook</span></b></a></span><b><span style="color:gray">
and </span></b><span style="color:#1F497D"><a href="http://twitter.com/productsteward"><b><span style="color:#4F81BD">Twitter</span></b></a>
</span><b><span style="color:gray">and</span></b><span style="color:#1F497D"> </span>
<b><span style="color:#4F81BD"><a href="http://productstewardshipinstitute.wordpress.com/"><span style="color:#4F81BD">Blog</span></a><o:p></o:p></span></b></p>
<p class="MsoNormal"><b><span style="color:#4F81BD"><o:p> </o:p></span></b></p>
</div>
</div>
</body>
</html>